ENX-102 for Generalized Anxiety Disorder (ENCALM Trial)

"This research is open to candidates who are mature enough and young enough. Specifically, those over 18 years old but under 65 years old may participate in the study."

"This trial necessitates 200 participants meeting the selection criteria to participate, with sites such as Woodland Research Northwest in Rogers, California and ProScience Research Group in Culver City, Florida accepting enrollees."

"The trial is actively recruiting, as indicated on clinicaltrials.gov, with the initial posting being made on July 3rd 2023 and most recently updated again on that same day."

"Our evaluation gave ENX-102 a score of 2, as this is only in Phase 2 trials and thus has evidence backing its safety but not necessarily its efficacy."

"Presently, 24 medical centres are participating in this trial. These locations include Rogers, Culver City and Garden Grove as well other sites throughout the country - it is advised that participants select a site close to them to reduce travelling demands."

"This trial is open to 200 individuals aged 18-65 that have been diagnosed with Generalized Anxiety Disorder according to DSM 5. To apply, they must meet the following criteria: any gender at birth (including all genders), confirmed via MINI 7.0.2, clinically significant levels of generalised anxiety and tension as evidenced by HAM-A scores ≥22 and item 1/2 both ≥ 2 on Screening day & Day 1 respectively."